Mink Therapeutics Inc (INKT)

Mink Therapeutics Inc (INKT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $52.2M; returns 1 day +6.5%, 1 week +13.8%, 1 year -24.4%.

MiNK Therapeutics, Inc. (INKT) is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies for cancer and immune-mediated diseases. The company's core technology involves off-the-shelf, allogeneic iNKT cell therapies that enhance both innate and adaptive immunity.

Groups INKT belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Clinical Stage
• Immunotherapy
• Oncology
• Cancer Therapeutics
• Biologics
• Healthcare
• Life Sciences

INKT financial model: income statement, cash flow and balance sheet